Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Nephrotic Syndrome

1-methyl-3-isobutylxanthine has been researched along with Nephrotic Syndrome in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birmelé, B1
De Agostini, A1
Girardin, EP1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Nephrotic Syndrome

ArticleYear
Role of cyclic AMP in idiopathic nephrotic syndrome: a pathway involving a decrease in glomerular cell heparan sulfates?
    Journal of cellular biochemistry, 2000, Jun-06, Volume: 78, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adult; Animals; Antimetabolites; Cells, Cultured; Child; Child, Prescho

2000